HOWL | NASDAQ

Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc. (HOWL) | runway 7.6 months | financing risk elevated | market cap $36M. Daily snapshot of financials, capital pressure, and recen...

Company websiteLast updated Apr 29, 2026

Share price

$0.68

As of Apr 29, 2026

Market cap

$36M

Snapshot valuation

30D volume

307,085 shares

Rolling average daily volume

Runway

7.6 months

Estimated from precomputed burn and cash

Financing risk

N/A

Current liquidity and financing setup suggest the company may need fresh capital in the near term.

Snapshot summary

Runway: 7.6 months based on estimated burn.

Financing signal: Current liquidity and financing setup suggest the company may need fresh capital in the near term.

Latest development: Werewolf Therapeutics, Inc. 10-K 2026-03-27.

Recent developments

Werewolf Therapeutics, Inc. 10-K 2026-03-27

10-K filed on 2026-03-27.

Mar 26, 2026, 8:00 PM

Werewolf Therapeutics, Inc. 8-K 2026-03-27

8-K filed on 2026-03-27.

Mar 26, 2026, 8:00 PM

Werewolf Therapeutics, Inc. 8-K 2026-02-24

8-K filed on 2026-02-24.

Feb 23, 2026, 7:00 PM

Werewolf Therapeutics, Inc. 8-K 2026-02-13

8-K filed on 2026-02-13.

Feb 12, 2026, 7:00 PM

Werewolf Therapeutics, Inc. 8-K 2026-02-06

8-K filed on 2026-02-06.

Feb 5, 2026, 7:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures